| 000 | 01746 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517181949.0 | ||
| 264 | 0 | _c20180326 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a0925-4439 | ||
| 024 | 7 |
_a10.1016/j.bbadis.2017.10.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Wen-Chung | |
| 245 | 0 | 0 |
_aOral pioglitazone ameliorates fructose-induced peripheral insulin resistance and hippocampal gliosis but not restores inhibited hippocampal adult neurogenesis. _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta. Molecular basis of disease _cJan 2018 |
||
| 300 |
_a274-285 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAdult Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aFructose _xadverse effects |
| 650 | 0 | 4 |
_aGliosis _xmetabolism |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeural Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aNeurogenesis _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 | _aPioglitazone |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred WKY |
| 650 | 0 | 4 |
_aThiazolidinediones _xadministration & dosage |
| 700 | 1 | _aWu, Chih-Wei | |
| 700 | 1 | _aTain, You-Lin | |
| 700 | 1 | _aFu, Mu-Hui | |
| 700 | 1 | _aHung, Chun-Ying | |
| 700 | 1 | _aChen, I-Chun | |
| 700 | 1 | _aChen, Lee-Wei | |
| 700 | 1 | _aWu, Kay L H | |
| 773 | 0 |
_tBiochimica et biophysica acta. Molecular basis of disease _gvol. 1864 _gno. 1 _gp. 274-285 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbadis.2017.10.017 _zAvailable from publisher's website |
| 999 |
_c27706736 _d27706736 |
||